☆ 4.2 Article

Codeine and morphine pathway

PHARMACOGENETICS AND GENOMICS (2009)

期刊

PHARMACOGENETICS AND GENOMICS

卷 19, 期 7, 页码 556-558

出版社

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1097/FPC.0b013e32832e0eac

关键词

codeine; drug metabolism; morphine; pathway; pharmacogenetics; pharmacogenomics; pharmacokinetics; variants

类别

Biotechnology & Applied Microbiology Genetics & Heredity Pharmacology & Pharmacy

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

主要评分

4.2

评分不足

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

Pharmacokinetics and transplacental transfer of codeine and codeine metabolites from Papaver somniferum L.

Jung-Hung Chen, I-Hsin Lin, Thomas Y. Hsueh, Jeffrey W. Dalley, Tung-Hu Tsai

Summary: This study aimed to investigate the metabolism, distribution, and transplacental transfer mechanism of codeine and its metabolites in pregnant rats, as well as to assess the risk of medication for pregnant women.

JOURNAL OF ETHNOPHARMACOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Genetic Variation among Pharmacogenes in the Sardinian Population

Maria Laura Idda, Magdalena Zoledziewska, Silvana Anna Maria Urru, Gregory McInnes, Alice Bilotta, Viola Nuvoli, Valeria Lodde, Sandro Orru, David Schlessinger, Francesco Cucca, Matteo Floris

Summary: Pharmacogenetics aims to identify the genetic factors that determine individual differences in drug response. This study investigated the pharmacogenetic variation in a sample set of Sardinians and found a high likelihood of atypical responses to multiple drugs in this population. Additionally, Sardinians showed a higher number of pharmacogenetic variants compared to other European populations, which may contribute to interpopulation variability in drug response phenotypes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Genetics & Heredity

Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic Relationships

Austin A. Saugstad, Natasha Petry, Catherine Hajek

Summary: As our understanding of genomics and genetic testing continues to advance, the personalization of medical decision making is progressing simultaneously. By carefully crafting medical care to fit the specific needs of the individual, patients can experience better long-term outcomes, reduced toxicities, and improved healthcare experiences. Studies have revealed diverse relationships between specific genetic variants and available therapies, ranging from well-documented clinical approaches to potential future applications.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans

Josefine Schulz, Robin Michelet, Markus Zeitlinger, Gerd Mikus, Charlotte Kloft

Summary: This study used microdialysis to assess the concentration of voriconazole (VRC) and its metabolite (NO) in the interstitial space fluid (ISF), in order to evaluate the drug's exposure at the target site and further understand its pharmacokinetics. The results showed that VRC and NO were distributed into the ISF, but at lower concentrations compared to plasma. The variability of metabolic ratios was influenced by multiple dosing and the CYP2C19 genotype. The study also revealed the saturation/auto-inhibition of VRC metabolism.

PHARMACEUTICAL RESEARCH (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics

Pablo Zubiaur, Paula Fernandez-Campos, Marcos Navares-Gomez, Paula Soria-Chacartegui, Gonzalo Villapalos-Garcia, Manuel Roman, Gina Mejia-Abril, Dolores Ochoa, Francisco Abad-Santos

Summary: This study investigated the impact of genetic variants in pharmacogenes on the pharmacokinetics of quetiapine, finding significant associations between COMT, CYP3A5, CYP2B6, and ABCG2 variants and quetiapine exposure. The discovery of potential COMT metabolites of quetiapine and the role of CYP enzymes in its metabolism suggest important mechanisms for quetiapine accumulation. Further research is needed to confirm the clinical relevance of these findings.

PHARMACEUTICS (2021)

添加到收藏夹

Article Oncology

Potentially actionable pharmacogenetic variants and symptom control medications in oncology

Jai N. Patel, Danielle Boselli, Elizabeth J. Jandrisevits, Issam S. Hamadeh, Ahmed Salem, Patrick Meadors, Declan Walsh

Summary: Approximately half of the patients received at least one symptom control medication, with the majority receiving SCMs with pharmacogenetic evidence. The study found a significant correlation between symptom severity and SCM prescribing.

SUPPORTIVE CARE IN CANCER (2021)

添加到收藏夹

Review Chemistry, Medicinal

Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug-Gene Pairs to Know

Tracy Sandritter, Rachel Chevalier, Rebecca Abt, Valentina Shakhnovich

Summary: Gastroenterologists have been early adopters of precision medicine through pharmacogenetic testing, specifically genotyping for TPMT before prescribing 6-mercaptopurine or azathioprine. While pharmacogenetic testing for drug dose individualization has become more available, interpreting results for drugs other than 6-mercaptopurine and azathioprine remains challenging, limiting widespread implementation of genotype-guided dosing.

PHARMACEUTICALS (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder

Katja Hakkinen, Wilma Kiander, Heidi Kidron, Markku Lahteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Isometsa, Tuula Kieseppa, Jouko Lonnqvist, Jaana Suvisaari, Jarmo Hietala, Jari Tiihonen, Aarno Palotie, Ari V. Ahola-Olli, Mikko Niemi

Summary: Six rare SLCO1B1 single nucleotide variants (SNVs) were identified in Finnish individuals with a psychotic disorder, which may affect the expression and functionality of the OATP1B1 protein. Functional studies showed that one of these SNVs (c.629G>T) resulted in the loss of OATP1B1 function and decreased membrane protein expression.

MOLECULAR PHARMACEUTICS (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Androstenedione (a Natural Steroid and a Drug Supplement): A Comprehensive Review of Its Consumption, Metabolism, Health Effects, and Toxicity with Sex Differences

Marwa T. Badawy, Mansour Sobeh, Jianbo Xiao, Mohamed A. Farag

Summary: Androstenedione is a key steroidal hormone that is used as a supplement by athletes to enhance athletic performance and muscle growth, known as "andro", but some of its effects are not scientifically proven and it is banned by the World Anti-Doping Agency and the International Olympic Committee.

MOLECULES (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone

Paula Soria-Chacartegui, Gonzalo Villapalos-Garcia, Pablo Zubiaur, Francisco Abad-Santos, Dora Koller

Summary: Olanzapine, aripiprazole, and risperidone are widely used for schizophrenia treatment and can induce various adverse drug reactions. The metabolism and individual genetic polymorphisms of these drugs affect pharmacokinetics and drug responses, necessitating consideration of patient genotypes and potential drug interactions during treatment.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

An Investigation of O-Demethyl Tramadol/Tramadol Ratio for Cytochrome P450 2D6 Phenotyping: The CYTRAM Study

Blandine De La Gastine, Soizic Percevault, Laurent Varin, Nicolas Richard, Fabienne Fobe, Benoit Plaud, Georges Daccache, Vincent Compere, Jean-Jacques Parienti, Antoine Coquerel, Magalie Loilier, Nathalie Bleyzac, Laurent Bourguignon, Sylvain Goutelle, Veronique Lelong-Boulouard

Summary: This study investigated the relationship between tramadol and CYP2D6 phenotype and found that tramadol is not suitable as a probe drug for CYP2D6 phenotyping.

PHARMACEUTICS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review

Bradley Roberts, Zahra Cooper, Stephanie Lu, Susanne Stanley, Bernadette T. Majda, Khan R. L. Collins, Lucy Gilkes, Jennifer Rodger, P. Anthony Akkari, Sean D. Hood

Summary: Pharmacogenetics (PGx) studies how individual genetic differences can affect drug responses. PGx testing can individualize primary care and provide a safer drug prescription model. It has shown promising evidence in improving drug efficacy and reducing toxicity in psychiatry. However, there are barriers hindering its implementation.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean

Aimee Salas-Hernandez, Macarena Galleguillos, Matias Carrasco, Andres Lopez-Cortes, Maria Ana Redal, Dora Fonseca-Mendoza, Patricia Esperon, Farith Gonzalez-Martinez, Ismael Lares-Asseff, Alberto Lazarowski, Veronica Loera-Castaneda, Diadelis Remirez, Matias F. Martinez, Rodrigo Vargas, Fabricio Rios-Santos, Antonio Macho, Juan P. Cayun, German R. Perez, Carolina Gutierrez, Leslie C. Cerpa, Tamara Leiva, Susan Calfunao, Lesly Xajil, Christopher Sandoval, Marcelo Suarez, Ariana Gonzalez, Gabriela Echeverria-Garces, Luis Sullon-Dextre, Eugenia Cordero-Garcia, Alexis R. Morales, Andrea Avendano, Enrique Sanchez, Laura C. Bastone, Cesar Lara, Patricia Zuluaga-Arias, Ana Maria Soler, Julio Da Luz, Gabriela Burgueno-Rodriguez, Marcelo Vital, Elizabeth Reyes-Reyes, Alexander Huaccha, Yeimy V. Ariza, Naomi Tzul, Ana L. Rendon, Roberto Serrano, Larissa Acosta, Angelo Motta-Pardo, Leonardo Beltran-Angarita, Erika Brand, Miguel A. Jimenez, Gladys Maribel Hidalgo-Lozada, Marina M. J. Romero-Prado, Karla Escobar-Castro, Mariel Umana-Rivas, Juan D. Vivas, Paola Lagos, Yineth Ballen Martinez, Sharleth Quesada, Camila Calfio, Maria L. Arias, Maria A. Lavanderos, Dante D. Caceres, Alberto Salazar-Granara, Nelson M. Varela, Luis A. Quinones

Summary: In this study, the authors reviewed pharmacogenomic knowledge and barriers to clinical application in the Latin American and Caribbean region. They found that this region has made limited contributions to the field and the primary barrier to implementation is the lack of guidelines and protocols. However, there have been improvements in the region's understanding and application of pharmacogenomics.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Veterinary Sciences

Genetic analysis of the equine orthologues for human CYP2D6: unraveling the complexity of the CYP2D family in horses

Giada Scantamburlo, Charity Nofziger, Markus Paulmichl, Simone Vanoni

Summary: This study aimed to elucidate the pharmacogenetic analysis of the CYP2D family in horses and resulted in the identification of a novel gene structure for CYP2D50, the expression of six different members of the CYP2D family in horse liver, and several novel polymorphisms for CYP2D50 and CYP2D82.

FRONTIERS IN VETERINARY SCIENCE (2023)

添加到收藏夹

Article Veterinary Sciences

Pharmacokinetics, adverse effects and effects on thermal nociception following administration of three doses of codeine to horses

Heather K. Knych, Kristen Stucker, Sophie R. Gretler, Philip H. Kass, Daniel S. McKemie

Summary: This study describes the metabolic profile and pharmacokinetics of codeine in horses, providing valuable information for future research on the analgesic effects of opioids in this species. The goal is to promote the safe and judicious use of this important class of drugs.

BMC VETERINARY RESEARCH (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype

John Henry McDermott, Joshua Wolf, Keito Hoshitsuki, Rachel Huddart, Kelly E. Caudle, Michelle Whirl-Carrillo, Peter S. Steyger, Richard J. H. Smith, Neal Cody, Cristina Rodriguez-Antona, Teri E. Klein, William G. Newman

Summary: The use of aminoglycosides is associated with the risk of hearing loss, particularly in individuals with MT-RNR1 gene variants. It is advisable to avoid using aminoglycosides in individuals with MT-RNR1 variants associated with an increased risk of aminoglycoside-induced hearing loss.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

PharmVar GeneFocus: CYP3A5

Cristina Rodriguez-Antona, Jessica L. Savieo, Volker M. Lauschke, Katrin Sangkuhl, Britt Drogemoller, Danxin Wang, Ron N. H. Schaik, Andrei A. Gilep, Arul P. Peter, Erin C. Boone, Bronwyn E. Ramey, Teri E. Klein, Michelle Whirl-Carrillo, Victoria M. Pratt, Andrea Gaedigk

Summary: This article introduces the star (*) allele nomenclature for the polymorphic human CYP3A5 gene in PharmVar, and summarizes the standardized nomenclature of this gene. Additionally, it discusses recent changes and updates, including the retirement of several allelic variants, and provides an overview of how the PharmVar CYP3A5 star allele nomenclature is utilized by PharmGKB and CPIC.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

PharmVar GeneFocus: SLCO1B1

Laura B. Ramsey, Li Gong, Seung-Been Lee, Jonathan B. Wagner, Xujia Zhou, Katrin Sangkuhl, Solomon M. Adams, Robert J. Straka, Philip E. Empey, Erin C. Boone, Teri E. Klein, Mikko Niemi, Andrea Gaedigk

Summary: PharmVar provides star allele nomenclature for the SLCO1B1 gene, which plays an important role in drug transport and metabolism. The standardized nomenclature has been adopted by CPIC and incorporated into guidelines.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

添加到收藏夹

Article Genetics & Heredity

ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

David T. Miller, Kristy Lee, Noura S. Abul-Husn, Laura M. Amendla, Kyle Brothers, Wendy K. Chung, Michael H. Gollob, Adam S. Gordon, Steven M. Harrison, Ray E. Hershberger, Teri E. Klein, Carolyn Sue Richards, Douglas R. Stewart, Christa Lese Martin

Summary: This statement serves as an educational resource for medical geneticists and clinicians, providing guidance for quality medical services. Clinicians are advised to use their professional judgment and document their reasons for specific procedures or tests. They should also be aware of the adoption date of this statement and consider potential intellectual property restrictions.

GENETICS IN MEDICINE (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

PharmGKB summary: acyclovir/ganciclovir pathway

Maud Maillard, Li Gong, Rina Nishii, Jun J. Yang, Michelle Whirl-Carrillo, Teri E. Klein

PHARMACOGENETICS AND GENOMICS (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype

Roseann S. Gammal, Munir Pirmohamed, Andrew A. Somogyi, Sarah A. Morris, Christine M. Formea, Amanda L. Elchynski, Kazeem A. Oshikoya, Howard L. McLeod, Cyrine E. Haidar, Michelle Whirl-Carrillo, Teri E. Klein, Kelly E. Caudle, Mary Relling

Summary: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with the development of acute hemolytic anemia in the presence of oxidative stress. This guideline provides information on using G6PD genotype for diagnosing G6PD deficiency and categorizes medications based on their risk level in individuals with G6PD deficiency. High-risk medications should be avoided, medium-risk medications should be used with caution, and low-risk medications can be used without considering the G6PD phenotype.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT)

Binglan Li, Katrin Sangkuhl, Karl Keat, Ryan M. M. Whaley, Mark Woon, Shefali Verma, Scott Dudek, Sony Tuteja, Anurag Verma, Michelle Whirl-Carrillo, Marylyn D. D. Ritchie, Teri E. E. Klein

Summary: Pharmacogenomics (PGx) investigates the genetic influence on drug response and is important for precision medicine. The challenge lies in interpreting PGx testing results for clinical decision support. PharmCAT has been designed to provide automatic interpretations of patient genetic data and generate reports with guideline recommendations. It has introduced new features, such as a VCF Preprocessor and functionalities for PGx research.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

Chad A. Bousman, James M. Stevenson, Laura B. Ramsey, Katrin Sangkuhl, J. Kevin Hicks, Jeffrey R. Strawn, Ajeet B. Singh, Gualberto Ruano, Daniel J. Mueller, Evangelia Eirini Tsermpini, Jacob T. Brown, Gillian C. Bell, J. Steven Leeder, Andrea Gaedigk, Stuart A. Scott, Teri E. Klein, Kelly E. Caudle, Jeffrey R. Bishop

Summary: Selective serotonin reuptake inhibitors (SSRIs) are the primary pharmacologic treatments for major depressive and anxiety disorders. Genetic variation in CYP2D6, CYP2C19, and CYP2B6 can affect the metabolism of these antidepressants, potentially impacting dosing, efficacy, and tolerability. The SLC6A4 and HTR2A genes have been studied for their relationship with efficacy and side effect profiles of these drugs. This guideline updates and expands on the role of genetic factors in antidepressant response and provides recommendations for using genotype results to guide prescribing decisions.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

添加到收藏夹

Article Genetics & Heredity

ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

David T. Miller, Kristy Lee, Noura S. Abul-Husn, Laura M. Amendola, Kyle Brothers, Wendy K. Chung, Michael H. Gollob, Adam S. Gordon, Steven M. Harrison, Ray E. Hershberger, Teri E. Klein, C. Sue Richards, Douglas R. Stewart, C. L. Martin

Summary: “Disclaimer: This statement is a voluntary educational resource for medical professionals, aimed at providing quality medical services. It does not guarantee successful medical outcomes and clinicians should use their own professional judgment in determining the appropriateness of specific procedures or tests. The views expressed may not reflect those of authors' employers or affiliated institutions.”

GENETICS IN MEDICINE (2023)

添加到收藏夹

Review Orthopedics

The Role of Epigenomics in Mapping Potential Precursors for Foot and Ankle Tendinopathy: A Systematic Review

Samantha Williams, Chandler Ligas, Lawrence Oloff, Teri E. E. Klein

Summary: Tendinopathy of the foot and ankle remains a poorly understood clinical problem. This article reviewed genomic advances in understanding the disease and its potential application in risk stratification and development of preventative or therapeutic agents. The research identified genetic risk factors, such as collagen gene polymorphisms, associated with chronic tendinopathy. Changes in the extracellular matrix and cytokine expression were also observed, which contribute to the pathology of tendinopathy. By targeting the underlying epigenetic mediators, therapeutic interventions can be developed to minimize side effects.

FOOT & ANKLE SPECIALIST (2023)

添加到收藏夹

Article Genetics & Heredity

Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank

Binglan Li, Katrin Sangkuhl, Ryan Whaley, Mark Woon, Karl Keat, Michelle Whirl-Carrillo, Marylyn D. Ritchie, Teri E. Klein

Summary: Pharmacogenomics is a crucial part of precision medicine. By analyzing genetic data from the UK Biobank, we estimated the pharmacogenomic frequencies in different biogeographic groups. The frequencies varied between each group. We also identified rare or seldom tested non-functional alleles that were previously overlooked. These estimated frequencies are disseminated through the Pharmacogenomics Knowledgebase, providing guidance for future research and clinical genetic testing.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting

Amy J. Turner, Charity Nofziger, Bronwyn E. Ramey, Reynold C. Ly, Chad A. Bousman, Jose A. G. Agundez, Katrin Sangkuhl, Michelle Whirl-Carrillo, Simone Vanoni, Henry M. Dunnenberger, Gualberto Ruano, Martin A. Kennedy, Michael S. Phillips, Houda Hachad, Teri E. Klein, Ann M. Moyer, Andrea Gaedigk

Summary: The Pharmacogene Variation Consortium (PharmVar) provides nomenclature and a comprehensive summary for the highly polymorphic human CYP2D6 gene locus and its structural variation. Accurate prediction of a patient’s CYP2D6 phenotype requires testing for structural variants, including gene deletions, duplications, hybrid genes, and combinations thereof.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

添加到收藏夹

Article Biotechnology & Applied Microbiology

PharmGKB summary: disulfiram pathway

Aneysis D. Gonzalez-Suarez, Caroline F. Thorn, Michelle Whirl-Carrillo, Teri E. Klein

PHARMACOGENETICS AND GENOMICS (2023)

添加到收藏夹

Meeting Abstract Biotechnology & Applied Microbiology

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

PHARMACOGENETICS AND GENOMICS (2023)

添加到收藏夹

Meeting Abstract Biotechnology & Applied Microbiology

Highly Scalable Pharmacogenomic Panel Testing with Hybrid Capture and Long-Read Sequencing

N. Gonzaludo, S. Kingan, J. Harting, P. Baybayan, T. Han, L. Arbiza, B. Li, K. Sangkuhl, M. Woon, R. Whaley, M. Whirl-Carrillo, Y. Yang, T. E. Klein, N. Hammond, S. A. Scott

PHARMACOGENETICS AND GENOMICS (2023)

添加到收藏夹

暂无数据

Codeine and morphine pathway

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS

关键词

类别

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

评论

主要评分

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

推荐

导出引文

分享论文